Transforming growth factor beta (TGF-β) signaling is critical to craniofacial development by directing bone resorption and formation, and heterozygous mutations in TGF-β type I receptor (TGFBR1) are associated with micrognathia in humans. The gene discussed is TGFB1; the disease is Micrognathia.